Sympathomimetic agent

A sympathomimetic agent is not a single molecule or receptor, but rather refers to any drug that mimics the effects of endogenous catecholamines—primarily epinephrine and norepinephrine—on the sympathetic nervous system. These compounds stimulate adrenergic receptors directly or indirectly to produce physiological responses such as increased heart rate, blood pressure elevation, bronchodilation, and enhanced alertness. They are used therapeutically in acute settings like cardiac arrest, anaphylaxis, asthma exacerbations, shock states requiring pressor support, and sometimes in chronic conditions like ADHD. The group includes both direct receptor agonists (e.g., epinephrine) and indirect acting stimulants that enhance neurotransmitter availability at synapses. Because "sympathomimetic agent" is a pharmacological class rather than an individual target molecule/receptor/protein/gene product—and can refer to many structurally diverse substances—it should not be considered a canonical therapeutic target itself.[1][2][3]

Other names

Sympathomimetic drugAdrenergic drugAdrenergic amineSympathomimetic medication

Sympathomimetic agents act by: - Directly stimulating adrenergic receptors (alpha and beta subtypes) - Indirectly increasing levels of endogenous catecholamines by promoting release or inhibiting reuptake/breakdown[1][2]. Examples: * Alpha agonists cause vasoconstriction. * Beta agonists increase heart rate/contractility or bronchodilation. * Indirect agents like amphetamines increase synaptic norepinephrine/dopamine.